Concourse Financial Group Securities, Inc. Astrazeneca PLC Transaction History
Concourse Financial Group Securities, Inc.
- $1.52 Billion
- Q1 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 19,735 shares of AZN stock, worth $1.57 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
19,735
Previous 18,819
4.87%
Holding current value
$1.57 Million
Previous $1.27 Million
5.52%
% of portfolio
0.09%
Previous 0.09%
Shares
23 transactions
Others Institutions Holding AZN
# of Institutions
1,246Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.89 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.92 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.42 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.75 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.38 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $247B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...